Meridian Bioscience, Inc. Reports First Quarter 2014 Operating Results, Declares Increased Regular Cash Dividend, And Reaffirms Fiscal 2014 Guidance

Meridian Bioscience, Inc. (NASDAQ: VIVO) today:

•reported first quarter net sales of $44.8 million, a decrease of 1% from the same period of the prior fiscal year;

•reported first quarter operating income of $11.6 million, a decrease of 11% from the same period of the prior fiscal year

Help employers find you! Check out all the jobs and post your resume.